| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | PMS1 RAD51D DHX36 KIF18A ERCC6 TDRD9 ATAD5 MCM3 MORC2 SMC2 RUVBL2 BLM DHX15 DNAH12 MDN1 DYNC1H1 MOV10 | 5.12e-08 | 441 | 153 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 5.90e-07 | 127 | 153 | 9 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | RAD51C PMS1 RAD51D DHX36 KIF18A ERCC6 TDRD9 ATAD5 MCM3 MORC2 SMC2 RUVBL2 BLM DHX15 DNAH12 MDN1 DYNC1H1 MOV10 | 1.16e-06 | 614 | 153 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | PMS1 RAD51D DHX36 KIF18A EFL1 RAP1GAP ERCC6 TDRD9 ATAD5 MCM3 MORC2 SMC2 RUVBL2 BLM DHX15 DNAH12 MDN1 DYNC1H1 MOV10 | 7.77e-06 | 775 | 153 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | molybdenum ion binding | 8.67e-06 | 6 | 153 | 3 | GO:0030151 | |
| GeneOntologyMolecularFunction | molybdopterin cofactor binding | 8.67e-06 | 6 | 153 | 3 | GO:0043546 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | RAD51C PMS1 RAD51D DHX36 AGO2 ERCC6 TDRD9 ATAD5 POLR2B MCM3 SAMHD1 RUVBL2 FAN1 BLM DHX15 AGO4 MOV10 | 9.56e-06 | 645 | 153 | 17 | GO:0140640 |
| GeneOntologyMolecularFunction | IgG receptor activity | 1.51e-05 | 7 | 153 | 3 | GO:0019770 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PMS1 RAD51D DHX36 KIF18A EFL1 RAP1GAP ERCC6 TDRD9 ATAD5 MCM3 MORC2 SMC2 RUVBL2 BLM DHX15 DNAH12 MDN1 DYNC1H1 MOV10 | 2.35e-05 | 839 | 153 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PMS1 RAD51D DHX36 KIF18A EFL1 RAP1GAP ERCC6 TDRD9 ATAD5 MCM3 MORC2 SMC2 RUVBL2 BLM DHX15 DNAH12 MDN1 DYNC1H1 MOV10 | 2.39e-05 | 840 | 153 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PMS1 RAD51D DHX36 KIF18A EFL1 RAP1GAP ERCC6 TDRD9 ATAD5 MCM3 MORC2 SMC2 RUVBL2 BLM DHX15 DNAH12 MDN1 DYNC1H1 MOV10 | 2.39e-05 | 840 | 153 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | helicase activity | 3.02e-05 | 158 | 153 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.53e-05 | 262 | 153 | 10 | GO:0140097 | |
| GeneOntologyMolecularFunction | nitrite reductase activity | 6.96e-05 | 11 | 153 | 3 | GO:0098809 | |
| GeneOntologyMolecularFunction | IgG binding | 6.96e-05 | 11 | 153 | 3 | GO:0019864 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 1.13e-04 | 62 | 153 | 5 | GO:0003678 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 1.51e-04 | 14 | 153 | 3 | GO:0019763 | |
| GeneOntologyMolecularFunction | nitrate reductase activity | 1.74e-04 | 3 | 153 | 2 | GO:0008940 | |
| GeneOntologyMolecularFunction | DNA-dependent protein kinase activity | 1.74e-04 | 3 | 153 | 2 | GO:0004677 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on other nitrogenous compounds as donors | 2.77e-04 | 17 | 153 | 3 | GO:0016661 | |
| GeneOntologyMolecularFunction | low-affinity IgG receptor activity | 3.46e-04 | 4 | 153 | 2 | GO:0019772 | |
| GeneOntologyMolecularFunction | four-way junction DNA binding | 3.91e-04 | 19 | 153 | 3 | GO:0000400 | |
| GeneOntologyMolecularFunction | ATP-dependent DNA damage sensor activity | 4.57e-04 | 20 | 153 | 3 | GO:0140664 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 5.88e-04 | 134 | 153 | 6 | GO:0003697 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring compression resistance | 6.98e-04 | 23 | 153 | 3 | GO:0030021 | |
| GeneOntologyMolecularFunction | DNA damage sensor activity | 7.93e-04 | 24 | 153 | 3 | GO:0140612 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 8.34e-04 | 55 | 153 | 4 | GO:0001046 | |
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 8.96e-04 | 25 | 153 | 3 | GO:0000979 | |
| GeneOntologyMolecularFunction | nitrite reductase (NO-forming) activity | 1.19e-03 | 7 | 153 | 2 | GO:0050421 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor | 1.19e-03 | 7 | 153 | 2 | GO:0016662 | |
| GeneOntologyMolecularFunction | E-box binding | 1.23e-03 | 61 | 153 | 4 | GO:0070888 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 2.62e-03 | 36 | 153 | 3 | GO:0019865 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 3.05e-03 | 78 | 153 | 4 | GO:0003724 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 3.05e-03 | 78 | 153 | 4 | GO:0003725 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 3.07e-03 | 11 | 153 | 2 | GO:0016303 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | RAD51C RAD51D ERCC6 SENP3 MCM3 SAMHD1 RUVBL2 FAN1 BLM SLF2 ATM SLX4 | 1.55e-08 | 188 | 152 | 12 | GO:0000724 |
| GeneOntologyBiologicalProcess | recombinational repair | RAD51C RAD51D ERCC6 SENP3 MCM3 SAMHD1 RUVBL2 FAN1 BLM SLF2 ATM SLX4 | 2.20e-08 | 194 | 152 | 12 | GO:0000725 |
| GeneOntologyBiologicalProcess | DNA recombination | RAD51C RAD51D ANKRD31 ERCC6 ATAD5 SENP3 MCM3 SAMHD1 MORC2 RUVBL2 FAN1 BLM SLF2 ATM SLX4 | 9.72e-08 | 368 | 152 | 15 | GO:0006310 |
| GeneOntologyBiologicalProcess | double-strand break repair | RAD51C RAD51D ATP23 ERCC6 SENP3 MCM3 SAMHD1 MORC2 RUVBL2 FAN1 BLM SLF2 ATM SLX4 | 1.30e-07 | 324 | 152 | 14 | GO:0006302 |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | RAD51C RAD51D ANKRD31 KIF18A TDRD9 MCM3 MORC2 SMC2 SGO1 AGO4 ATM SLX4 | 7.35e-07 | 268 | 152 | 12 | GO:1903046 |
| GeneOntologyBiologicalProcess | DNA repair | RAD51C PMS1 RAD51D CHAF1B ATP23 ERCC6 SENP3 MCM3 SAMHD1 MORC2 SMC2 RUVBL2 FAN1 BLM SLF2 ATM TAF9 SLX4 | 1.43e-06 | 648 | 152 | 18 | GO:0006281 |
| GeneOntologyBiologicalProcess | meiotic nuclear division | RAD51C RAD51D ANKRD31 KIF18A TDRD9 MORC2 SMC2 SGO1 AGO4 ATM SLX4 | 1.73e-06 | 240 | 152 | 11 | GO:0140013 |
| GeneOntologyBiologicalProcess | DNA metabolic process | RAD51C PMS1 RAD51D ANKRD31 DHX36 CHAF1B ATP23 ERCC6 ATAD5 SENP3 MCM3 SAMHD1 MORC2 SMC2 NHP2 RUVBL2 GRHL2 FAN1 BLM SLF2 ATM TAF9 SLX4 | 4.39e-06 | 1081 | 152 | 23 | GO:0006259 |
| GeneOntologyBiologicalProcess | telomere maintenance | 4.41e-06 | 168 | 152 | 9 | GO:0000723 | |
| GeneOntologyBiologicalProcess | reciprocal meiotic recombination | 9.99e-06 | 67 | 152 | 6 | GO:0007131 | |
| GeneOntologyBiologicalProcess | reciprocal homologous recombination | 9.99e-06 | 67 | 152 | 6 | GO:0140527 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | RAD51C RAD51D ANKRD31 KIF18A TDRD9 MCM3 MORC2 SMC2 SGO1 AGO4 ATM SLX4 | 1.15e-05 | 350 | 152 | 12 | GO:0051321 |
| GeneOntologyBiologicalProcess | chromosome organization | RAD51C RAD51D ANKRD31 DHX36 KIF18A MCM3 NSL1 MORC2 SMC2 SGO1 NHP2 RUVBL2 BLM AGO4 SLF2 ATM SLX4 | 1.28e-05 | 686 | 152 | 17 | GO:0051276 |
| GeneOntologyBiologicalProcess | meiosis I | 1.36e-05 | 147 | 152 | 8 | GO:0007127 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to antigenic stimulus | 1.39e-05 | 42 | 152 | 5 | GO:0002438 | |
| GeneOntologyBiologicalProcess | telomere organization | 1.73e-05 | 199 | 152 | 9 | GO:0032200 | |
| GeneOntologyBiologicalProcess | homologous recombination | 1.78e-05 | 74 | 152 | 6 | GO:0035825 | |
| GeneOntologyBiologicalProcess | meiosis I cell cycle process | 1.99e-05 | 155 | 152 | 8 | GO:0061982 | |
| GeneOntologyBiologicalProcess | positive regulation of chromosome organization | 2.07e-05 | 113 | 152 | 7 | GO:2001252 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell proliferation | 2.25e-05 | 23 | 152 | 4 | GO:0030889 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 3.18e-05 | 25 | 152 | 4 | GO:0002524 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 3.19e-05 | 9 | 152 | 3 | GO:0001810 | |
| GeneOntologyBiologicalProcess | RNA secondary structure unwinding | 3.19e-05 | 9 | 152 | 3 | GO:0010501 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 4.53e-05 | 10 | 152 | 3 | GO:0016068 | |
| GeneOntologyBiologicalProcess | negative regulation of type I hypersensitivity | 5.40e-05 | 2 | 152 | 2 | GO:0001811 | |
| GeneOntologyBiologicalProcess | male meiotic nuclear division | 8.02e-05 | 60 | 152 | 5 | GO:0007140 | |
| GeneOntologyBiologicalProcess | DNA damage response | RAD51C PMS1 RAD51D CHAF1B ATP23 ERCC6 ATAD5 SENP3 MCM3 SAMHD1 MORC2 SMC2 RUVBL2 FAN1 BLM SLF2 ATM TAF9 SLX4 | 8.39e-05 | 959 | 152 | 19 | GO:0006974 |
| GeneOntologyBiologicalProcess | acute inflammatory response | 9.30e-05 | 143 | 152 | 7 | GO:0002526 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 1.06e-04 | 13 | 152 | 3 | GO:0001788 | |
| GeneOntologyBiologicalProcess | nuclear division | RAD51C RAD51D ANKRD31 KIF18A TDRD9 NSL1 MORC2 SMC2 SGO1 AGO4 MTBP ATM SLX4 | 1.11e-04 | 512 | 152 | 13 | GO:0000280 |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 1.67e-04 | 15 | 152 | 3 | GO:0001794 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 1.67e-04 | 15 | 152 | 3 | GO:0002445 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 1.86e-04 | 333 | 152 | 10 | GO:0051054 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA processing | 2.18e-04 | 74 | 152 | 5 | GO:0070918 | |
| GeneOntologyBiologicalProcess | chromosome organization involved in meiotic cell cycle | 2.32e-04 | 75 | 152 | 5 | GO:0070192 | |
| GeneOntologyBiologicalProcess | sexual reproduction | RAD51C RAD51D ANKRD31 DHX36 KIF18A TDRD9 TBPL1 SYT6 ASH1L MCM3 CNBD2 MORC2 SMC2 SGO1 JAG2 HOXA9 SOHLH2 IGF2R AGO4 ATM CFAP57 SLX4 | 2.51e-04 | 1312 | 152 | 22 | GO:0019953 |
| GeneOntologyBiologicalProcess | negative regulation of B cell activation | 2.55e-04 | 42 | 152 | 4 | GO:0050869 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | ANKRD31 DHX36 ERCC6 ATAD5 SENP3 MCM3 RUVBL2 GRHL2 BLM SLF2 ATM TAF9 SLX4 | 2.85e-04 | 564 | 152 | 13 | GO:0051052 |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 2.90e-04 | 122 | 152 | 6 | GO:0045132 | |
| GeneOntologyBiologicalProcess | negative regulation of acute inflammatory response | 2.95e-04 | 18 | 152 | 3 | GO:0002674 | |
| GeneOntologyBiologicalProcess | regulation of B cell proliferation | 3.14e-04 | 80 | 152 | 5 | GO:0030888 | |
| GeneOntologyBiologicalProcess | siRNA-mediated post-transcriptional gene silencing | 3.21e-04 | 4 | 152 | 2 | GO:0140766 | |
| GeneOntologyBiologicalProcess | siRNA-mediated gene silencing by mRNA destabilization | 3.21e-04 | 4 | 152 | 2 | GO:0090625 | |
| GeneOntologyBiologicalProcess | negative regulation of hypersensitivity | 3.21e-04 | 4 | 152 | 2 | GO:0002884 | |
| GeneOntologyBiologicalProcess | nitrate metabolic process | 3.21e-04 | 4 | 152 | 2 | GO:0042126 | |
| GeneOntologyBiologicalProcess | organelle fission | RAD51C RAD51D ANKRD31 KIF18A TDRD9 NSL1 MORC2 SMC2 SGO1 AGO4 MTBP ATM SLX4 | 3.21e-04 | 571 | 152 | 13 | GO:0048285 |
| GeneOntologyBiologicalProcess | regulation of hypersensitivity | 3.49e-04 | 19 | 152 | 3 | GO:0002883 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 3.49e-04 | 19 | 152 | 3 | GO:0002921 | |
| GeneOntologyBiologicalProcess | miRNA processing | 4.29e-04 | 48 | 152 | 4 | GO:0035196 | |
| GeneOntologyBiologicalProcess | protein-RNA complex assembly | 4.64e-04 | 244 | 152 | 8 | GO:0022618 | |
| GeneOntologyBiologicalProcess | regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway | 5.32e-04 | 5 | 152 | 2 | GO:1903381 | |
| GeneOntologyBiologicalProcess | type III hypersensitivity | 5.32e-04 | 5 | 152 | 2 | GO:0001802 | |
| GeneOntologyBiologicalProcess | regulation of type III hypersensitivity | 5.32e-04 | 5 | 152 | 2 | GO:0001803 | |
| GeneOntologyBiologicalProcess | positive regulation of type III hypersensitivity | 5.32e-04 | 5 | 152 | 2 | GO:0001805 | |
| GeneOntologyBiologicalProcess | cellular detoxification of nitrogen compound | 5.32e-04 | 5 | 152 | 2 | GO:0070458 | |
| GeneOntologyBiologicalProcess | negative regulation of neutrophil apoptotic process | 5.32e-04 | 5 | 152 | 2 | GO:0033030 | |
| GeneOntologyBiologicalProcess | detoxification of nitrogen compound | 5.32e-04 | 5 | 152 | 2 | GO:0051410 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA 3'-end processing | 5.32e-04 | 5 | 152 | 2 | GO:0031442 | |
| GeneOntologyBiologicalProcess | DNA double-strand break processing | 5.45e-04 | 22 | 152 | 3 | GO:0000729 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 6.05e-04 | 254 | 152 | 8 | GO:0071826 | |
| GeneOntologyBiologicalProcess | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 7.94e-04 | 6 | 152 | 2 | GO:0036483 | |
| GeneOntologyBiologicalProcess | positive regulation of phagocytosis | 8.34e-04 | 99 | 152 | 5 | GO:0050766 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-10 production | 9.01e-04 | 26 | 152 | 3 | GO:0032693 | |
| GeneOntologyBiologicalProcess | inflammatory response to antigenic stimulus | 9.97e-04 | 103 | 152 | 5 | GO:0002437 | |
| GeneOntologyBiologicalProcess | mitotic recombination | 1.01e-03 | 27 | 152 | 3 | GO:0006312 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to antigenic stimulus | 1.01e-03 | 27 | 152 | 3 | GO:0002864 | |
| GeneOntologyBiologicalProcess | Fc receptor-mediated immune complex endocytosis | 1.11e-03 | 7 | 152 | 2 | GO:0160006 | |
| GeneOntologyBiologicalProcess | positive regulation of trophoblast cell migration | 1.11e-03 | 7 | 152 | 2 | GO:1901165 | |
| GeneOntologyBiologicalProcess | G-quadruplex DNA unwinding | 1.11e-03 | 7 | 152 | 2 | GO:0044806 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 1.13e-03 | 62 | 152 | 4 | GO:0038093 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 6.11e-06 | 176 | 153 | 9 | GO:0000781 | |
| GeneOntologyCellularComponent | chromosomal region | RAD51D DHX36 KIF18A POLR2B MCM3 NSL1 SGO1 NHP2 BLM SLF2 MTBP ATM SLX4 | 1.39e-05 | 421 | 153 | 13 | GO:0098687 |
| GeneOntologyCellularComponent | MLL1 complex | 8.46e-05 | 32 | 153 | 4 | GO:0071339 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 9.57e-05 | 33 | 153 | 4 | GO:0044665 | |
| GeneOntologyCellularComponent | endonuclease complex | 2.73e-04 | 43 | 153 | 4 | GO:1905348 | |
| GeneOntologyCellularComponent | Rad51B-Rad51C-Rad51D-XRCC2 complex | 3.16e-04 | 4 | 153 | 2 | GO:0033063 | |
| GeneOntologyCellularComponent | Holliday junction resolvase complex | 5.25e-04 | 5 | 153 | 2 | GO:0048476 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | RAD51C PCGF2 AGO2 ATP23 TBPL1 POLR2B MCM3 NCBP1 RUVBL2 FBXL4 AGO4 UBE3D TAF9 TAF1L SMURF2 SLX4 DCAF12 | 7.80e-04 | 972 | 153 | 17 | GO:0140535 |
| GeneOntologyCellularComponent | endodeoxyribonuclease complex | 7.83e-04 | 6 | 153 | 2 | GO:1905347 | |
| GeneOntologyCellularComponent | DNA recombinase mediator complex | 1.09e-03 | 7 | 153 | 2 | GO:0033061 | |
| GeneOntologyCellularComponent | pronucleus | 1.10e-03 | 28 | 153 | 3 | GO:0045120 | |
| GeneOntologyCellularComponent | germ plasm | 1.22e-03 | 29 | 153 | 3 | GO:0060293 | |
| GeneOntologyCellularComponent | pole plasm | 1.22e-03 | 29 | 153 | 3 | GO:0045495 | |
| GeneOntologyCellularComponent | P granule | 1.22e-03 | 29 | 153 | 3 | GO:0043186 | |
| GeneOntologyCellularComponent | dynactin complex | 1.45e-03 | 8 | 153 | 2 | GO:0005869 | |
| GeneOntologyCellularComponent | nuclear DNA-directed RNA polymerase complex | 1.46e-03 | 113 | 153 | 5 | GO:0055029 | |
| GeneOntologyCellularComponent | DNA-directed RNA polymerase complex | 1.64e-03 | 116 | 153 | 5 | GO:0000428 | |
| GeneOntologyCellularComponent | RNA polymerase complex | 1.84e-03 | 119 | 153 | 5 | GO:0030880 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.24e-03 | 75 | 153 | 4 | GO:0035097 | |
| GeneOntologyCellularComponent | RISC-loading complex | 2.30e-03 | 10 | 153 | 2 | GO:0070578 | |
| GeneOntologyCellularComponent | replication fork | 2.47e-03 | 77 | 153 | 4 | GO:0005657 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RAD51C PMS1 RAD51D PCGF2 ATP23 ERCC6 TBPL1 POLR2B SENP3 NUP88 MCM3 NHP2 RUVBL2 DHX15 NEUROD1 CCNL1 PWP2 TAF9 TAF1L SLX4 | 2.57e-03 | 1377 | 153 | 20 | GO:0140513 |
| MousePheno | arrest of spermatogenesis | RAD51C ANKRD31 KIF18A TDRD9 TBPL1 CNBD2 MORC2 SOHLH2 ATM FAR1 | 2.96e-05 | 239 | 116 | 10 | MP:0001155 |
| MousePheno | decreased spinal cord ventral horn cell number | 6.83e-05 | 2 | 116 | 2 | MP:0005113 | |
| MousePheno | abnormal spermatocyte morphology | 6.88e-05 | 84 | 116 | 6 | MP:0006379 | |
| MousePheno | abnormal locomotor coordination | MAG EFL1 TRIM2 ARHGAP10 LAMB1 MORC2 PREX2 NEUROD1 NEUROD2 DST FCGR2A ACAN ASPA ATM HYDIN DYNC1H1 EPHA4 | 9.86e-05 | 726 | 116 | 17 | MP:0003312 |
| MousePheno | decreased oocyte number | 1.37e-04 | 95 | 116 | 6 | MP:0005431 | |
| MousePheno | abnormal oocyte number | 1.45e-04 | 96 | 116 | 6 | MP:0020152 | |
| MousePheno | abnormal oocyte morphology | 1.49e-04 | 138 | 116 | 7 | MP:0001125 | |
| MousePheno | female infertility | RAD51C KIF18A TMEM248 TMC7 ASH1L MORC2 JAG2 SOHLH2 IGF2R PADI6 ATM PARP12 | 1.51e-04 | 410 | 116 | 12 | MP:0001926 |
| MousePheno | abnormal oogenesis | 1.58e-04 | 186 | 116 | 8 | MP:0001931 | |
| MousePheno | arrest of male meiosis | 1.63e-04 | 140 | 116 | 7 | MP:0008261 | |
| MousePheno | abnormal male reproductive system physiology | RAD51C ANKRD31 KIF18A TMC7 TDRD9 TBPL1 ASH1L XDH CNBD2 MORC2 OPHN1 CS SOHLH2 IGF2R AGO4 ATM CFAP57 FAR1 HYDIN ABHD16A SLX4 DYNC1H1 RNF133 EPHA4 | 1.99e-04 | 1329 | 116 | 24 | MP:0003698 |
| MousePheno | abnormal male meiosis | 2.18e-04 | 195 | 116 | 8 | MP:0005169 | |
| MousePheno | abnormal female germ cell morphology | 2.50e-04 | 150 | 116 | 7 | MP:0006361 | |
| MousePheno | infertility | RAD51C ANKRD31 KIF18A TMEM248 TMC7 TDRD9 TBPL1 ASH1L XDH CNBD2 MORC2 JAG2 SOHLH2 IGF2R PADI6 ATM CFAP57 FAR1 HYDIN ABHD16A DYNC1H1 PARP12 | 2.72e-04 | 1188 | 116 | 22 | MP:0001924 |
| MousePheno | chromosomal instability | 2.90e-04 | 109 | 116 | 6 | MP:0008866 | |
| Domain | Neurogenic_DUF | 1.86e-06 | 4 | 146 | 3 | IPR022575 | |
| Domain | Neuro_bHLH | 1.86e-06 | 4 | 146 | 3 | PF12533 | |
| Domain | TF_bHLH_NeuroD | 1.86e-06 | 4 | 146 | 3 | IPR016637 | |
| Domain | AAA | 1.98e-06 | 144 | 146 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 1.98e-06 | 144 | 146 | 9 | IPR003593 | |
| Domain | - | RAD51C RAD51D DHX36 EFL1 ERCC6 TDRD9 ATAD5 MCM3 SMC2 RUVBL2 BLM DHX15 NLRP9 DNAH12 MDN1 HYDIN DYNC1H1 MOV10 | 2.16e-05 | 746 | 146 | 18 | 3.40.50.300 |
| Domain | P-loop_NTPase | RAD51C RAD51D DHX36 KIF18A EFL1 ERCC6 TDRD9 ATAD5 MCM3 SMC2 RUVBL2 BLM DHX15 NLRP9 DNAH12 MDN1 HYDIN DYNC1H1 MOV10 | 3.47e-05 | 848 | 146 | 19 | IPR027417 |
| Domain | Arp1 | 6.07e-05 | 2 | 146 | 2 | IPR029909 | |
| Domain | ATPase_dyneun-rel_AAA | 1.60e-04 | 14 | 146 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.60e-04 | 14 | 146 | 3 | PF07728 | |
| Domain | MOSC | 1.81e-04 | 3 | 146 | 2 | PF03473 | |
| Domain | MOSC_N | 1.81e-04 | 3 | 146 | 2 | PF03476 | |
| Domain | MOSC | 1.81e-04 | 3 | 146 | 2 | PS51340 | |
| Domain | MOSC_N | 1.81e-04 | 3 | 146 | 2 | IPR005303 | |
| Domain | MoCF_Sase_C | 1.81e-04 | 3 | 146 | 2 | IPR005302 | |
| Domain | HA2 | 3.50e-04 | 18 | 146 | 3 | SM00847 | |
| Domain | HA2 | 3.50e-04 | 18 | 146 | 3 | PF04408 | |
| Domain | Helicase-assoc_dom | 3.50e-04 | 18 | 146 | 3 | IPR007502 | |
| Domain | Argonaute_N | 3.60e-04 | 4 | 146 | 2 | IPR032474 | |
| Domain | Argonaute_Mid_dom | 3.60e-04 | 4 | 146 | 2 | IPR032473 | |
| Domain | ArgoL2 | 3.60e-04 | 4 | 146 | 2 | IPR032472 | |
| Domain | ArgoN | 3.60e-04 | 4 | 146 | 2 | PF16486 | |
| Domain | ArgoMid | 3.60e-04 | 4 | 146 | 2 | PF16487 | |
| Domain | ArgoL2 | 3.60e-04 | 4 | 146 | 2 | PF16488 | |
| Domain | Pyrv_Knase-like_insert_dom | 5.98e-04 | 5 | 146 | 2 | IPR011037 | |
| Domain | DUF1785 | 5.98e-04 | 5 | 146 | 2 | SM01163 | |
| Domain | - | 8.92e-04 | 6 | 146 | 2 | 3.90.1290.10 | |
| Domain | Rad51_DMC1_RadA | 8.92e-04 | 6 | 146 | 2 | IPR033925 | |
| Domain | ArgoL1 | 8.92e-04 | 6 | 146 | 2 | PF08699 | |
| Domain | ArgoL1 | 8.92e-04 | 6 | 146 | 2 | IPR014811 | |
| Domain | DNA_recomb/repair_RecA-like | 8.92e-04 | 6 | 146 | 2 | IPR016467 | |
| Domain | Ricin_B_lectin | 9.49e-04 | 25 | 146 | 3 | PF00652 | |
| Domain | DNA_recomb/repair_Rad51_C | 1.24e-03 | 7 | 146 | 2 | IPR013632 | |
| Domain | RecA_ATP-bd | 1.24e-03 | 7 | 146 | 2 | IPR020588 | |
| Domain | RECA_2 | 1.24e-03 | 7 | 146 | 2 | PS50162 | |
| Domain | Plectin | 1.24e-03 | 7 | 146 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.24e-03 | 7 | 146 | 2 | IPR001101 | |
| Domain | Rad51 | 1.24e-03 | 7 | 146 | 2 | PF08423 | |
| Domain | PLEC | 1.24e-03 | 7 | 146 | 2 | SM00250 | |
| Domain | RICIN | 1.33e-03 | 28 | 146 | 3 | SM00458 | |
| Domain | RICIN_B_LECTIN | 1.33e-03 | 28 | 146 | 3 | PS50231 | |
| Domain | Helicase_C | 1.53e-03 | 107 | 146 | 5 | PF00271 | |
| Domain | HELICc | 1.53e-03 | 107 | 146 | 5 | SM00490 | |
| Domain | Helicase_C | 1.59e-03 | 108 | 146 | 5 | IPR001650 | |
| Domain | Ricin_B_lectin | 1.63e-03 | 30 | 146 | 3 | IPR000772 | |
| Domain | Glycos_transf_2 | 1.63e-03 | 30 | 146 | 3 | PF00535 | |
| Domain | Glyco_trans_2-like | 1.63e-03 | 30 | 146 | 3 | IPR001173 | |
| Domain | PIWI | 1.65e-03 | 8 | 146 | 2 | PS50822 | |
| Domain | Piwi | 1.65e-03 | 8 | 146 | 2 | SM00950 | |
| Domain | TMC | 1.65e-03 | 8 | 146 | 2 | PF07810 | |
| Domain | Piwi | 1.65e-03 | 8 | 146 | 2 | PF02171 | |
| Domain | Piwi | 1.65e-03 | 8 | 146 | 2 | IPR003165 | |
| Domain | TMC | 1.65e-03 | 8 | 146 | 2 | IPR012496 | |
| Domain | HELICASE_CTER | 1.66e-03 | 109 | 146 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.66e-03 | 109 | 146 | 5 | PS51192 | |
| Domain | DEXDc | 1.66e-03 | 109 | 146 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.73e-03 | 110 | 146 | 5 | IPR014001 | |
| Domain | PAZ | 2.11e-03 | 9 | 146 | 2 | PS50821 | |
| Domain | PAZ | 2.11e-03 | 9 | 146 | 2 | SM00949 | |
| Domain | PAZ | 2.11e-03 | 9 | 146 | 2 | PF02170 | |
| Domain | ZU5 | 2.11e-03 | 9 | 146 | 2 | SM00218 | |
| Domain | PAZ_dom | 2.11e-03 | 9 | 146 | 2 | IPR003100 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.55e-03 | 35 | 146 | 3 | IPR002464 | |
| Domain | DEAD/DEAH_box_helicase_dom | 2.57e-03 | 73 | 146 | 4 | IPR011545 | |
| Domain | DEAD | 2.57e-03 | 73 | 146 | 4 | PF00270 | |
| Domain | A2M | 2.62e-03 | 10 | 146 | 2 | PF00207 | |
| Domain | A2M_N_2 | 2.62e-03 | 10 | 146 | 2 | IPR011625 | |
| Domain | A2M_comp | 2.62e-03 | 10 | 146 | 2 | IPR011626 | |
| Domain | A2M_recep | 2.62e-03 | 10 | 146 | 2 | PF07677 | |
| Domain | A2M_comp | 2.62e-03 | 10 | 146 | 2 | PF07678 | |
| Domain | A2M_N | 2.62e-03 | 10 | 146 | 2 | PF01835 | |
| Domain | A2M_N | 2.62e-03 | 10 | 146 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.62e-03 | 10 | 146 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.62e-03 | 10 | 146 | 2 | PS00477 | |
| Domain | ZU5 | 2.62e-03 | 10 | 146 | 2 | PS51145 | |
| Domain | A2M_N_2 | 2.62e-03 | 10 | 146 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 2.62e-03 | 10 | 146 | 2 | IPR001599 | |
| Domain | DEAH_ATP_HELICASE | 3.23e-03 | 38 | 146 | 3 | PS00690 | |
| Domain | ZU5 | 3.80e-03 | 12 | 146 | 2 | PF00791 | |
| Domain | ZU5_dom | 3.80e-03 | 12 | 146 | 2 | IPR000906 | |
| Domain | I-BAR_dom | 4.47e-03 | 13 | 146 | 2 | IPR013606 | |
| Domain | - | 4.47e-03 | 13 | 146 | 2 | 2.10.10.10 | |
| Domain | NHL | 4.47e-03 | 13 | 146 | 2 | PS51125 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.19e-03 | 14 | 146 | 2 | IPR024317 | |
| Domain | FN_type2_col-bd | 5.19e-03 | 14 | 146 | 2 | IPR000562 | |
| Domain | FN2_2 | 5.19e-03 | 14 | 146 | 2 | PS51092 | |
| Domain | Dynein_heavy_dom-2 | 5.19e-03 | 14 | 146 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.19e-03 | 14 | 146 | 2 | PF08393 | |
| Domain | FN2_1 | 5.19e-03 | 14 | 146 | 2 | PS00023 | |
| Domain | AAA_8 | 5.19e-03 | 14 | 146 | 2 | PF12780 | |
| Domain | fn2 | 5.19e-03 | 14 | 146 | 2 | PF00040 | |
| Domain | FN2 | 5.19e-03 | 14 | 146 | 2 | SM00059 | |
| Domain | DHC_fam | 5.96e-03 | 15 | 146 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 5.96e-03 | 15 | 146 | 2 | PF03028 | |
| Domain | PI3/4_kinase_CS | 5.96e-03 | 15 | 146 | 2 | IPR018936 | |
| Domain | Dynein_heavy_dom | 5.96e-03 | 15 | 146 | 2 | IPR004273 | |
| Domain | - | 6.78e-03 | 16 | 146 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 6.78e-03 | 16 | 146 | 2 | SM00146 | |
| Domain | Actin_CS | 6.78e-03 | 16 | 146 | 2 | IPR004001 | |
| Domain | 7tm_2 | 7.01e-03 | 50 | 146 | 3 | PF00002 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 1.04e-05 | 35 | 119 | 5 | MM15293 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 1.38e-05 | 37 | 119 | 5 | M27583 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 4.75e-05 | 9 | 119 | 3 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 4.75e-05 | 9 | 119 | 3 | M46436 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 6.25e-05 | 26 | 119 | 4 | MM15297 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 6.74e-05 | 10 | 119 | 3 | M48013 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA | 7.29e-05 | 27 | 119 | 4 | M27586 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 1.37e-04 | 59 | 119 | 5 | MM15283 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 1.58e-04 | 13 | 119 | 3 | M46434 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 3.08e-04 | 70 | 119 | 5 | M27570 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 3.66e-04 | 17 | 119 | 3 | M27788 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 4.62e-04 | 43 | 119 | 4 | M27588 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 5.15e-04 | 19 | 119 | 3 | M48238 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX36 AGO2 ERCC6 DSP TBPL1 POLR2B SENP3 MCM3 SMC2 NHP2 RUVBL2 HNRNPL BLM DHX15 ACTR1B ACTR1A SRRT RIN1 CS DST MDN1 AKAP13 FAR1 DYNC1H1 MOV10 PARP12 | 2.87e-10 | 1353 | 154 | 26 | 29467282 |
| Pubmed | CHAF1B RAP1GAP PCGF2 ANK2 DSP ASH1L LAMB1 NCBP1 ZNF302 NHP2 FAN1 FOCAD CS NEUROD2 DST SLF2 ASPA ATM EIF2AK1 NEUROD6 SMURF2 SLX4 DYNC1H1 | 1.29e-08 | 1285 | 154 | 23 | 35914814 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX36 DSP POLR2B NUP88 MCM3 NCBP1 SAMHD1 SMC2 NHP2 RUVBL2 HNRNPL DHX15 ACTR1A SRRT CS IGF2R MDN1 PWP2 ATM GALNT5 PEAK1 FAR1 DYNC1H1 ADGRA3 | 1.92e-08 | 1425 | 154 | 24 | 30948266 |
| Pubmed | A2M PMS1 CHAF1B AGO2 DSP POLR2B NUP88 LAMB1 MORC2 RUVBL2 HNRNPL DHX15 CS GALNT5 EIF2AK1 DYNC1H1 MOV10 | 4.73e-08 | 754 | 154 | 17 | 35906200 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 26133275 | ||
| Pubmed | Functional Fcgamma receptor polymorphisms are associated with human allergy. | 8.51e-08 | 3 | 154 | 3 | 24586589 | |
| Pubmed | Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk. | 9.91e-08 | 84 | 154 | 7 | 19237606 | |
| Pubmed | DHX36 CHAF1B AGO2 POLR2B MCM3 NCBP1 SAMHD1 SMC2 NHP2 RUVBL2 HNRNPL DHX15 SRRT MDN1 FAR1 DYNC1H1 | 1.60e-07 | 725 | 154 | 16 | 27025967 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | MAG DHX36 AGO2 CCDC127 NCBP1 TENM2 HNRNPL PRKD3 AGO4 PWP2 MTARC2 MOV10 PARP12 | 1.62e-07 | 462 | 154 | 13 | 31138677 |
| Pubmed | Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. | 2.06e-07 | 57 | 154 | 6 | 17932509 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DHX36 KIF18A ERCC6 ATAD5 POLR2B SENP3 NCBP1 SAMHD1 SMC2 RUVBL2 BLM SRRT MDN1 PWP2 FAR1 MOV10 | 2.96e-07 | 759 | 154 | 16 | 35915203 |
| Pubmed | NeuroD factors regulate cell fate and neurite stratification in the developing retina. | 3.39e-07 | 4 | 154 | 3 | 21593321 | |
| Pubmed | Differentially regulated expression and function of CD22 in activated B-1 and B-2 lymphocytes. | 3.39e-07 | 4 | 154 | 3 | 12055217 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EFL1 TBPL1 POLR2B NUP88 MCM3 SAMHD1 MORC2 SMC2 RUVBL2 HNRNPL ACTR1A TIMM21 TAF9 DYNC1H1 MOV10 | 6.20e-07 | 704 | 154 | 15 | 29955894 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | AGO2 DSP ASH1L MCM3 NCBP1 RUVBL2 HNRNPL DHX15 ACTR1A CS DST MDN1 AKAP13 PEAK1 HYDIN DYNC1H1 | 6.64e-07 | 807 | 154 | 16 | 30575818 |
| Pubmed | Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. | 8.46e-07 | 5 | 154 | 3 | 16709748 | |
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 19309690 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 20439936 | ||
| Pubmed | Copy number, linkage disequilibrium and disease association in the FCGR locus. | 8.46e-07 | 5 | 154 | 3 | 20508037 | |
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 12975363 | ||
| Pubmed | PMS1 KIF18A EFL1 AGO2 DSP ATAD5 ARHGAP10 POLR2B NCBP1 SGO1 HNRNPL FAN1 BLM CNNM4 IGF2R PTPRM PEAK1 SLC29A1 | 1.03e-06 | 1049 | 154 | 18 | 27880917 | |
| Pubmed | DHX36 ERCC6 SENP3 NCBP1 SMC2 NHP2 RUVBL2 HNRNPL DHX15 ZNF462 ACTR1B ACTR1A MDN1 PWP2 FAR1 MOV10 | 1.25e-06 | 847 | 154 | 16 | 35850772 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CHAF1B DSP ATAD5 POLR2B SENP3 NUP88 SMC2 NHP2 RUVBL2 HNRNPL BLM DHX15 SRRT DST MDN1 SLF2 ELF4 TIGD5 TAF9 TAF1L | 1.25e-06 | 1294 | 154 | 20 | 30804502 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RAD51C DHX36 AGO2 DSP POLR2B MCM3 NCBP1 SAMHD1 SMC2 RUVBL2 HNRNPL DHX15 PTOV1 ACTR1A MDN1 TIMM21 FAR1 TAF9 DYNC1H1 | 3.25e-06 | 1257 | 154 | 19 | 37317656 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CHAF1B DSP POLR2B MCM3 NCBP1 SMC2 RUVBL2 HNRNPL DHX15 SRRT CS IGF2R DST MDN1 PWP2 FAR1 DYNC1H1 | 3.26e-06 | 1024 | 154 | 17 | 24711643 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NUP88 PER1 LAMB1 XDH NSL1 SGO1 NHP2 RUVBL2 BLM DHX15 ACTR1B ACTR1A ZMYM1 ATM SLX4 DYNC1H1 MOV10 DCAF12 | 3.96e-06 | 1155 | 154 | 18 | 20360068 |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | CHAF1B POLR2B NUP88 MCM3 SAMHD1 RUVBL2 HNRNPL DHX15 PTOV1 ACTR1A CS MDN1 FAR1 | 4.58e-06 | 624 | 154 | 13 | 33729478 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | KIF18A POLR2B NSL1 NHP2 RUVBL2 HNRNPL DHX15 SRRT AKAP13 PEAK1 | 5.24e-06 | 361 | 154 | 10 | 30344098 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DSP NCBP1 SAMHD1 HNRNPL FOCAD NEUROD2 DST MDN1 AKAP13 MTARC2 EEF1AKMT1 ATM CFAP57 DYNC1H1 | 5.51e-06 | 736 | 154 | 14 | 29676528 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DHX36 TBPL1 POLR2B SENP3 MCM3 NCBP1 SMC2 NHP2 RUVBL2 HNRNPL DHX15 CS MDN1 BTK PWP2 FAR1 TAF9 DYNC1H1 MOV10 | 6.40e-06 | 1318 | 154 | 19 | 30463901 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 6.50e-06 | 370 | 154 | 10 | 22922362 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | KIF18A ARHGAP10 NUP88 MCM3 SMC2 BLM PTOV1 ACTR1B CNNM4 ACTR1A RIN1 CS UBE3D XPO6 ARFGAP3 EIF2AK1 DYNC1H1 MTARC1 MOV10 | 6.61e-06 | 1321 | 154 | 19 | 27173435 |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 6.80e-06 | 157 | 154 | 7 | 30686591 | |
| Pubmed | 7.01e-06 | 9 | 154 | 3 | 28130357 | ||
| Pubmed | A2M PMS1 DHX36 RAP1GAP SENP3 MORC2 SMC2 RUVBL2 SRRT DST AKAP13 PZP PARP12 | 7.10e-06 | 650 | 154 | 13 | 38777146 | |
| Pubmed | 7.13e-06 | 222 | 154 | 8 | 37071664 | ||
| Pubmed | A2M CHAF1B DSP ATAD5 POLR2B LAMB1 MCM3 SMC2 RUVBL2 HNRNPL BLM DHX15 SRRT | 7.33e-06 | 652 | 154 | 13 | 31180492 | |
| Pubmed | 7.37e-06 | 223 | 154 | 8 | 20020773 | ||
| Pubmed | DHX36 DSP NUP88 NCBP1 BLM DHX15 IGF2R DST MDN1 PWP2 ATM DYNC1H1 MOV10 | 7.45e-06 | 653 | 154 | 13 | 22586326 | |
| Pubmed | 8.55e-06 | 107 | 154 | 6 | 11347906 | ||
| Pubmed | 1.06e-05 | 31 | 154 | 4 | 15960975 | ||
| Pubmed | EFL1 CHAF1B ATAD5 POLR2B MCM3 NCBP1 MORC2 SMC2 RUVBL2 BLM DHX15 SRRT MDN1 PWP2 ATM TAF9 | 1.21e-05 | 1014 | 154 | 16 | 32416067 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | A2M DHX36 ERCC6 DSP POLR2B SENP3 MCM3 NCBP1 SMC2 RUVBL2 HNRNPL DHX15 ACTR1A SRRT DST PWP2 DYNC1H1 MOV10 | 1.25e-05 | 1257 | 154 | 18 | 36526897 |
| Pubmed | 1.33e-05 | 68 | 154 | 5 | 20496165 | ||
| Pubmed | RAP1GAP PER1 MORC2 FAN1 ZNF462 CNNM4 PEAK1 EIF2AK1 SLX4 MOV10 DCAF12 | 1.35e-05 | 493 | 154 | 11 | 15368895 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.38e-05 | 175 | 154 | 7 | 25756610 | |
| Pubmed | 1.41e-05 | 244 | 154 | 8 | 29884807 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ERCC6 POLR2B MORC2 NHP2 BLM DNAH12 MDN1 PIK3C2B ATM GALNT5 HYDIN | 1.46e-05 | 497 | 154 | 11 | 36774506 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PMS1 CHAF1B ERCC6 ATAD5 NCBP1 NSL1 MORC2 SGO1 NHP2 BLM ZNF462 CCNL1 | 1.84e-05 | 608 | 154 | 12 | 36089195 |
| Pubmed | Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection. | 1.95e-05 | 2 | 154 | 2 | 23616574 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 19284648 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17548594 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 25904149 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 21078890 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 33616086 | ||
| Pubmed | Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb-/- lupus model. | 1.95e-05 | 2 | 154 | 2 | 33861790 | |
| Pubmed | FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthma. | 1.95e-05 | 2 | 154 | 2 | 20179765 | |
| Pubmed | Respiratory syncytial virus persistence in macrophages upregulates Fcgamma receptors expression. | 1.95e-05 | 2 | 154 | 2 | 24509813 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 21477339 | ||
| Pubmed | Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia. | 1.95e-05 | 2 | 154 | 2 | 32684632 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 11983693 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 34248948 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 9454850 | ||
| Pubmed | Negative regulation of c-kit-mediated cell proliferation by Fc gamma RIIB. | 1.95e-05 | 2 | 154 | 2 | 10201978 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 20083655 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 2531080 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 2138787 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 8069908 | ||
| Pubmed | Genetic control of T-cell proliferative response in mice linked to chromosomes 11 and 15. | 1.95e-05 | 2 | 154 | 2 | 8824160 | |
| Pubmed | Regulation of allograft survival by inhibitory FcγRIIb signaling. | 1.95e-05 | 2 | 154 | 2 | 23150718 | |
| Pubmed | The proneural genes NEUROD1 and NEUROD2 are expressed during human trophoblast invasion. | 1.95e-05 | 2 | 154 | 2 | 11900979 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 29597194 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 21357255 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 24366619 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 19223321 | ||
| Pubmed | Differences in endocytosis mediated by FcγRIIA and FcγRIIB2. | 1.95e-05 | 2 | 154 | 2 | 21945020 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 16925577 | ||
| Pubmed | FcγRIIb on liver sinusoidal endothelium clears small immune complexes. | 1.95e-05 | 2 | 154 | 2 | 23053513 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 21803866 | ||
| Pubmed | A complementary DNA clone for a macrophage-lymphocyte Fc receptor. | 1.95e-05 | 2 | 154 | 2 | 3024012 | |
| Pubmed | Human rhinovirus type 2-antibody complexes enter and infect cells via Fc-gamma receptor IIB1. | 1.95e-05 | 2 | 154 | 2 | 14990693 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 10704470 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 3161943 | ||
| Pubmed | Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer. | 1.95e-05 | 2 | 154 | 2 | 33657816 | |
| Pubmed | Lipopolysaccharide Impedes Bone Repair in FcγRIIB-Deficient Mice. | 1.95e-05 | 2 | 154 | 2 | 38069267 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 10704418 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 1692292 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 37539049 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 26057125 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23897982 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 16757681 | ||
| Pubmed | FcγRIIb attenuates TLR4‑mediated NF‑κB signaling in B cells. | 1.95e-05 | 2 | 154 | 2 | 28849025 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23053716 | ||
| Pubmed | Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells. | 1.95e-05 | 2 | 154 | 2 | 15843524 | |
| Pubmed | BLM and SLX4 play opposing roles in recombination-dependent replication at human telomeres. | 1.95e-05 | 2 | 154 | 2 | 28877996 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 29190833 | ||
| Pubmed | Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8. | 1.95e-05 | 2 | 154 | 2 | 27384482 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 18957413 | ||
| Pubmed | Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice. | 1.95e-05 | 2 | 154 | 2 | 19644866 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 21969314 | ||
| Interaction | TRIM28 interactions | EFL1 CHAF1B TBPL1 POLR2B SENP3 NUP88 MCM3 NCBP1 SAMHD1 ZNF302 MORC2 SMC2 RUVBL2 HNRNPL DHX15 ZNF462 ACTR1A SRRT TIMM21 UBE3D ZNF701 ATM TAF9 SMURF2 SLX4 DYNC1H1 MOV10 | 1.12e-05 | 1474 | 150 | 27 | int:TRIM28 |
| Interaction | HSF1 interactions | DENND5B CHAF1B PCGF2 AGO2 DSP POLR2B NUP88 LAMB1 MCM3 NCBP1 MORC2 RUVBL2 HNRNPL DHX15 TAF9 MOV10 | 1.29e-05 | 609 | 150 | 16 | int:HSF1 |
| Interaction | DSCR9 interactions | 1.45e-05 | 147 | 150 | 8 | int:DSCR9 | |
| GeneFamily | Immunoglobulin like domain containing|Adhesion G protein-coupled receptors, subfamily A | 1.14e-04 | 3 | 112 | 2 | 911 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.04e-03 | 8 | 112 | 2 | 939 | |
| GeneFamily | Argonaute/PIWI family | 1.04e-03 | 8 | 112 | 2 | 408 | |
| GeneFamily | Transmembrane channel likes | 1.04e-03 | 8 | 112 | 2 | 1135 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.33e-03 | 9 | 112 | 2 | 1234 | |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 1.01e-06 | 230 | 152 | 10 | M11563 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | A2M TMC7 DSP UNC5B TMC6 PER1 LAMB1 GALNT18 JAG2 PRKD3 CKMT2 MDN1 FCGR2A PTPRM CCNL1 PEAK1 PZP CXCL8 PARP12 | 1.01e-06 | 888 | 152 | 19 | M39049 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | RAD51C RAD51D KIF18A CHAF1B ATP23 ATAD5 SLC43A1 MCM3 NSL1 SMC2 SGO1 RUVBL2 BLM TIMM21 FAR1 SLC29A1 | 2.99e-06 | 694 | 152 | 16 | M45767 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | RAD51C KIF18A CHAF1B RAP1GAP AGO2 ATP23 ATAD5 SENP3 NUP88 MCM3 NCBP1 SMC2 HNRNPL BLM DHX15 PRKD3 FADS3 TIMM21 SLF2 UBE3D FAR1 SLC29A1 | 5.55e-06 | 1290 | 152 | 22 | M80 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RAD51C PMS1 TRIM2 AGO2 POLR2B SEMA5A BLM DHX15 IGF2R DST MDN1 PTPRM XPO6 AKAP13 SMURF2 ADGRA3 EPHA4 | 1.04e-05 | 856 | 152 | 17 | M4500 |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_EXCITATORY_NEURON | 1.05e-05 | 8 | 152 | 3 | M39075 | |
| Coexpression | GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 2.29e-05 | 200 | 152 | 8 | M7446 | |
| Coexpression | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP | A2M ANK2 DSP SLC43A1 SAMHD1 PRELP ACAN CCNL1 ASPA AKAP13 CXCL8 | 4.18e-05 | 427 | 152 | 11 | M17923 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | RAP1GAP PCGF2 AGO2 ANK2 NUP88 MORC2 JAG2 PTOV1 IGF2R FADS3 PTPRM AKAP13 ATM ADGRA3 PARP12 | 5.88e-05 | 790 | 152 | 15 | M12490 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | KIF18A RAP1GAP AGO2 ERCC6 ATAD5 MCM3 NCBP1 SAMHD1 SMC2 BLM PRKD3 ACTR1B DST SLF2 ZNF701 ZMYM1 | 6.47e-05 | 892 | 152 | 16 | M18120 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP | 7.80e-05 | 176 | 152 | 7 | M8881 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | KIF18A CHAF1B ATAD5 SLC43A1 MCM3 NSL1 SMC2 SGO1 BLM FADS3 BTK TSPAN6 | 4.16e-05 | 422 | 148 | 12 | GSM538355_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | RAD51C PMS1 KIF18A ERCC6 DSP SENP3 NUP88 MCM3 NHP2 BLM ZNF462 SOHLH2 MDN1 PIK3C2B ZMYM1 ATM PARP12 | 6.15e-05 | 822 | 148 | 17 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.07e-04 | 266 | 148 | 9 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 | |
| CoexpressionAtlas | B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3 | KIF18A CHAF1B ATAD5 SLC43A1 MCM3 NSL1 SMC2 SGO1 BLM BTK TSPAN6 | 1.18e-04 | 400 | 148 | 11 | GSM538358_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.18e-04 | 333 | 148 | 10 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | RAD51C DENND5B KIF18A CHAF1B ATAD5 MCM3 NSL1 SMC2 SGO1 BLM BTK | 1.43e-04 | 409 | 148 | 11 | GSM399452_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | RAD51C PMS1 KIF18A DSP NUP88 MCM3 SGO1 NHP2 BLM SOHLH2 MDN1 EEF1AKMT1 ZMYM1 ATM MOV10 PARP12 | 1.48e-04 | 799 | 148 | 16 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 1.55e-04 | 164 | 148 | 7 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k2_500 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | KIF18A CHAF1B ATAD5 SLC43A1 MCM3 NSL1 SMC2 SGO1 BLM TSPAN6 MTBP | 1.69e-04 | 417 | 148 | 11 | GSM399403_500 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | KIF18A CHAF1B ATAD5 SLC43A1 MCM3 SMC2 SGO1 BLM FADS3 BTK TSPAN6 | 1.73e-04 | 418 | 148 | 11 | GSM538350_500 |
| CoexpressionAtlas | alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2 | KIF18A CHAF1B ATAD5 SLC43A1 MCM3 NSL1 SMC2 SGO1 BLM TSPAN6 ADGRA3 | 1.80e-04 | 420 | 148 | 11 | GSM791141_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | KIF18A CHAF1B ATAD5 MCM3 NSL1 SMC2 SGO1 BLM FADS3 BTK TSPAN6 | 1.88e-04 | 422 | 148 | 11 | GSM538357_500 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | DENND5B CHAF1B TRIM2 AGO2 ATAD5 LAMB1 SEMA5A SGO1 BLM HOXA9 PTPRM UBE3D HAS2 ADGRA3 EPHA4 | 2.41e-04 | 749 | 148 | 15 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | DENND5B CHAF1B TRIM2 LAMB1 SEMA5A SGO1 HOXA9 PTPRM HAS2 EPHA4 | 2.77e-04 | 370 | 148 | 10 | gudmap_kidney_P3_CapMes_Crym_500 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.91e-04 | 129 | 148 | 6 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k3 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | DENND5B KIF18A ATAD5 MCM3 SMC2 SGO1 FCGR2B PIK3C2B BTK DCAF12 | 3.42e-04 | 380 | 148 | 10 | GSM538207_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | RAD51C PMS1 KIF18A DSP NUP88 MCM3 SGO1 NHP2 BLM SOHLH2 MDN1 ZMYM1 ATM MOV10 PARP12 | 3.75e-04 | 781 | 148 | 15 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | DENND5B CHAF1B TRIM2 AGO2 DSP LAMB1 SEMA5A GRHL2 GALNT18 BLM HOXA9 HAS2 TAF9 ADGRA3 EPHA4 | 3.85e-04 | 783 | 148 | 15 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_500 | 3.87e-04 | 386 | 148 | 10 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_500 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.43e-08 | 200 | 154 | 9 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-08 | 150 | 154 | 8 | 322aa0c3fc159a4b2897daac881dfc744b24ffc4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-07 | 186 | 154 | 8 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 195 | 154 | 8 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.78e-07 | 199 | 154 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.78e-07 | 199 | 154 | 8 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.78e-07 | 199 | 154 | 8 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-06 | 177 | 154 | 7 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.04e-06 | 179 | 154 | 7 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.52e-06 | 183 | 154 | 7 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.52e-06 | 183 | 154 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | BL-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.92e-06 | 186 | 154 | 7 | 27d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8 | |
| ToppCell | BAL-Control-cDC_7|Control / Compartment, Disease Groups and Clusters | 4.05e-06 | 121 | 154 | 6 | b49b044a687a31883dfccecf10a183b5ba567f7a | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.06e-06 | 187 | 154 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.36e-06 | 189 | 154 | 7 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 189 | 154 | 7 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.67e-06 | 191 | 154 | 7 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.67e-06 | 191 | 154 | 7 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.83e-06 | 192 | 154 | 7 | 1f35efb0765e05f7f9c881849953bef3965be25a | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 5.00e-06 | 193 | 154 | 7 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-06 | 193 | 154 | 7 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-06 | 193 | 154 | 7 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-06 | 193 | 154 | 7 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.17e-06 | 194 | 154 | 7 | 8a4be91414a2e69dd410aa75791f16008204c9a1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.35e-06 | 195 | 154 | 7 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.35e-06 | 195 | 154 | 7 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.35e-06 | 195 | 154 | 7 | a432d69b0172211ee4d53675936a1dc9ce1ae1f0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.35e-06 | 195 | 154 | 7 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.53e-06 | 196 | 154 | 7 | ae46d4b00be92e64e46252dcc156161b171eded4 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.53e-06 | 196 | 154 | 7 | cf7f384c1771274e766bab03ecc3dfbd13f2df60 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.53e-06 | 196 | 154 | 7 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.53e-06 | 196 | 154 | 7 | de70cc301a8cbaedb0a5ea4a6442dcdaa477822d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.72e-06 | 197 | 154 | 7 | 98e34e8612f111bb667a574de1faaa785d318ca4 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.72e-06 | 197 | 154 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.72e-06 | 197 | 154 | 7 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.91e-06 | 198 | 154 | 7 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.91e-06 | 198 | 154 | 7 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-06 | 198 | 154 | 7 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.91e-06 | 198 | 154 | 7 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.91e-06 | 198 | 154 | 7 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.11e-06 | 199 | 154 | 7 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.11e-06 | 199 | 154 | 7 | b15304d3d3f6c254969b54a61bee3d9f368840b2 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.11e-06 | 199 | 154 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.11e-06 | 199 | 154 | 7 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | 6.11e-06 | 199 | 154 | 7 | e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.11e-06 | 199 | 154 | 7 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.11e-06 | 199 | 154 | 7 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.31e-06 | 200 | 154 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.31e-06 | 200 | 154 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.31e-06 | 200 | 154 | 7 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-05 | 152 | 154 | 6 | dbfb4d4de36ef9f5c7da1950baa915b12788685e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-05 | 152 | 154 | 6 | 9f3682da00fd627e80aa820ecc6f5fed23b9738a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-05 | 156 | 154 | 6 | ff39712c7a2dc1b85c598d5105789aa291dea726 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 165 | 154 | 6 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.46e-05 | 166 | 154 | 6 | 07b498eb341abec02a3ccaae320bdbb5cd6883c5 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-05 | 170 | 154 | 6 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-05 | 170 | 154 | 6 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-05 | 174 | 154 | 6 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-05 | 174 | 154 | 6 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-05 | 174 | 154 | 6 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-05 | 174 | 154 | 6 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 3.31e-05 | 175 | 154 | 6 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.42e-05 | 176 | 154 | 6 | 71f96cace3f20fbef975037f4deff9b82b0282a1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-05 | 176 | 154 | 6 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-05 | 178 | 154 | 6 | 5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.76e-05 | 179 | 154 | 6 | 42f3c040f504a91cc69292d39d22b5715c12526f | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.76e-05 | 179 | 154 | 6 | 063c05753ef1b4a18bc1ebbcae62c8cd25d11070 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-05 | 179 | 154 | 6 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.76e-05 | 179 | 154 | 6 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | COVID-19_Moderate-RBC|World / disease group, cell group and cell class | 3.76e-05 | 179 | 154 | 6 | 932fa98c0981ef8ef1e4945cdd4ae8c6c0858251 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 179 | 154 | 6 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 3.88e-05 | 180 | 154 | 6 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-05 | 180 | 154 | 6 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Zbtb20_(Ventral_Hippocampus)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.03e-05 | 110 | 154 | 5 | ff196c71aa2a21cdd812958bd163fa6b91bd2352 | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.03e-05 | 110 | 154 | 5 | 438bf761ab0a25e3dc9244c23ae2c2d68a169c7f | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Zbtb20_(Ventral_Hippocampus)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.03e-05 | 110 | 154 | 5 | 46635a130453c2fa304f0e09561b2a267c9ceb31 | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.03e-05 | 110 | 154 | 5 | 3639fb5fc02eca509cb220295bc3e6064c23baab | |
| ToppCell | PBMC-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 4.13e-05 | 182 | 154 | 6 | 4774066d0f9986abc3d13a2a3bc99ce4f1327ae0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.25e-05 | 183 | 154 | 6 | d23018193b9c0806e0d1a9ac15e6392eb8e96aaf | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.25e-05 | 183 | 154 | 6 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 4.39e-05 | 184 | 154 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-05 | 187 | 154 | 6 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-05 | 187 | 154 | 6 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.80e-05 | 187 | 154 | 6 | b426a67b5669019115b58295ce7d304beeb75825 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.80e-05 | 187 | 154 | 6 | d01926be1c8846a25fb6706e26b56b808b69f8f0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 4.80e-05 | 187 | 154 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.94e-05 | 188 | 154 | 6 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 4.94e-05 | 188 | 154 | 6 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 188 | 154 | 6 | 14e120b20e76baa07b6510a94f0c2dcdfdd52357 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 4.94e-05 | 188 | 154 | 6 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.09e-05 | 189 | 154 | 6 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.09e-05 | 189 | 154 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-05 | 189 | 154 | 6 | 16dfc37d8d390ed7f927bc844c47c9c5a89a0928 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-05 | 189 | 154 | 6 | 443359d90fafae0c1de6bdcce9e8c95df6ea4de8 | |
| Computational | Genes in the cancer module 98. | RAD51C PMS1 RAD51D CHAF1B DSP NUP88 PER1 MCM3 SMC2 BLM ACTR1B ACTR1A ELF4 | 8.34e-05 | 393 | 102 | 13 | MODULE_98 |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.05e-04 | 50 | 102 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Genes in the cancer module 318. | 1.31e-04 | 28 | 102 | 4 | MODULE_318 | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; MCF7; HT_HG-U133A | RAD51D TMC7 ARHGAP10 FBXL4 FAN1 CNNM4 FADS3 MTARC2 ATM PARP12 | 8.53e-07 | 198 | 151 | 10 | 2633_DN |
| Drug | MDL 20,610 | 2.83e-06 | 5 | 151 | 3 | CID000128209 | |
| Drug | mitomycin C | 4.98e-06 | 241 | 151 | 10 | CID000005746 | |
| Drug | TAN-1030A | 5.64e-06 | 6 | 151 | 3 | CID009576886 | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; PC3; HT_HG-U133A | PCGF2 TRIM2 ATAD5 ARHGAP10 SEMA5A CNNM4 ACTR1A EIF2AK1 EPHA4 | 7.84e-06 | 200 | 151 | 9 | 6303_DN |
| Drug | AC1MHTIN | 9.82e-06 | 7 | 151 | 3 | CID003011133 | |
| Drug | TAN-999 | 9.82e-06 | 7 | 151 | 3 | CID000130283 | |
| Drug | Intravenous Immunoglobulin | 1.56e-05 | 8 | 151 | 3 | DB00028 | |
| Drug | AC1NSK5W | 2.33e-05 | 9 | 151 | 3 | CID005311182 | |
| Drug | methyl methanesulfonate | RAD51C RAD51D CHAF1B ERCC6 TBPL1 SMC2 BLM PRKD3 AGO4 ELF4 ATM | 3.28e-05 | 364 | 151 | 11 | CID000004156 |
| Drug | Palivizumab | 3.32e-05 | 10 | 151 | 3 | DB00110 | |
| Drug | Denny-Jaffe reagent | 3.32e-05 | 10 | 151 | 3 | CID003035979 | |
| Drug | ethylphenylpropiolate | 4.37e-05 | 2 | 151 | 2 | ctd:C015202 | |
| Drug | 8-bromoadenosine-3',5'-cyclic monophosphorothioate | 4.37e-05 | 2 | 151 | 2 | ctd:C105593 | |
| Drug | 17-bromoheptadecanoate | 4.37e-05 | 2 | 151 | 2 | CID000083135 | |
| Drug | Bevacizumab | 4.54e-05 | 11 | 151 | 3 | DB00112 | |
| Drug | Tositumomab | 4.54e-05 | 11 | 151 | 3 | DB00081 | |
| Drug | Alemtuzumab | 4.54e-05 | 11 | 151 | 3 | DB00087 | |
| Drug | Efalizumab | 4.54e-05 | 11 | 151 | 3 | DB00095 | |
| Drug | Alefacept | 4.54e-05 | 11 | 151 | 3 | DB00092 | |
| Drug | splitomicin; Up 200; 20uM; PC3; HG-U133A | 4.72e-05 | 194 | 151 | 8 | 661_UP | |
| Drug | SB 203580; Down 200; 1uM; MCF7; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 6899_DN | |
| Drug | copper(II) sulfate pentahydrate; Up 200; 100uM; MCF7; HG-U133A | 5.26e-05 | 197 | 151 | 8 | 438_UP | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 3305_DN | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; PC3; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 4093_DN | |
| Drug | Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 6479_DN | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 5.65e-05 | 199 | 151 | 8 | 6795_UP | |
| Drug | Cocaine | AGO2 DSP ATAD5 NUP88 PER1 CCDC127 LAMB1 XDH SEMA5A NCBP1 CNBD2 TENM2 OPHN1 JAG2 PTOV1 ACAN BTK CCNL1 ADGRA1 ATM CXCL8 EPHA4 | 5.67e-05 | 1314 | 151 | 22 | ctd:D003042 |
| Drug | Diflunisal [22494-42-4]; Up 200; 16uM; PC3; HG-U133A | 5.86e-05 | 200 | 151 | 8 | 1908_UP | |
| Drug | Daclizumab | 6.02e-05 | 12 | 151 | 3 | DB00111 | |
| Drug | Natalizumab | 6.02e-05 | 12 | 151 | 3 | DB00108 | |
| Drug | Rituximab | 6.02e-05 | 12 | 151 | 3 | DB00073 | |
| Drug | Ibritumomab | 6.02e-05 | 12 | 151 | 3 | DB00078 | |
| Drug | Adalimumab | 6.02e-05 | 12 | 151 | 3 | DB00051 | |
| Drug | Gemtuzumab ozogamicin | 6.02e-05 | 12 | 151 | 3 | DB00056 | |
| Drug | Cetuximab | 6.02e-05 | 12 | 151 | 3 | DB00002 | |
| Drug | AC1L9JJ0 | 6.55e-05 | 33 | 151 | 4 | CID000446336 | |
| Drug | Trastuzumab | 7.79e-05 | 13 | 151 | 3 | DB00072 | |
| Drug | Basiliximab | 7.79e-05 | 13 | 151 | 3 | DB00074 | |
| Drug | imiquimod | 8.33e-05 | 67 | 151 | 5 | ctd:C056493 | |
| Drug | AC1L1ERT | 9.59e-05 | 69 | 151 | 5 | CID000002920 | |
| Drug | Abciximab | 9.87e-05 | 14 | 151 | 3 | DB00054 | |
| Drug | Etanercept | 9.87e-05 | 14 | 151 | 3 | DB00005 | |
| Drug | Muromonab | 1.23e-04 | 15 | 151 | 3 | DB00075 | |
| Drug | 2-Br | 1.28e-04 | 39 | 151 | 4 | CID000007244 | |
| Disease | malaria (implicated_via_orthology) | 1.04e-05 | 9 | 149 | 3 | DOID:12365 (implicated_via_orthology) | |
| Disease | Breast Cancer, Familial | 1.55e-05 | 30 | 149 | 4 | C0346153 | |
| Disease | Ashkenazi Jewish disorders | 2.02e-05 | 11 | 149 | 3 | cv:CN118946 | |
| Disease | X-linked agammaglobulinemia with growth hormone deficiency | 2.53e-05 | 2 | 149 | 2 | C0472813 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 8.15e-05 | 17 | 149 | 3 | EFO_0021969 | |
| Disease | Carcinoma of bladder | 9.74e-05 | 18 | 149 | 3 | C0699885 | |
| Disease | Malignant neoplasm of breast | RAD51C RAP1GAP ERCC6 ANK2 PER1 XDH HNRNPL JAG2 CNNM4 NLRP9 ARFGAP3 BTK ATM GALNT5 G6PC1 CXCL8 | 1.12e-04 | 1074 | 149 | 16 | C0006142 |
| Disease | potassium voltage-gated channel subfamily E regulatory beta subunit 5 measurement | 1.51e-04 | 4 | 149 | 2 | EFO_0801902 | |
| Disease | Hereditary breast ovarian cancer syndrome | 1.51e-04 | 4 | 149 | 2 | cv:C0677776 | |
| Disease | X-linked mental retardation with cerebellar hypoplasia and distinctive facial appearance (implicated_via_orthology) | 1.51e-04 | 4 | 149 | 2 | DOID:0080311 (implicated_via_orthology) | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 2.51e-04 | 5 | 149 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | Glioblastoma Multiforme | 2.56e-04 | 111 | 149 | 5 | C1621958 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-b measurement | 2.67e-04 | 25 | 149 | 3 | EFO_0021970 | |
| Disease | Acute monocytic leukemia | 3.01e-04 | 26 | 149 | 3 | C0023465 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 3.38e-04 | 27 | 149 | 3 | C1112155 | |
| Disease | Malignant tumor of breast | 3.38e-04 | 27 | 149 | 3 | cv:C0006142 | |
| Disease | Breast neoplasm | 3.38e-04 | 27 | 149 | 3 | cv:C1458155 | |
| Disease | Familial cancer of breast | 3.38e-04 | 27 | 149 | 3 | cv:C0346153 | |
| Disease | SYSTEMIC LUPUS ERYTHEMATOSUS | 3.75e-04 | 6 | 149 | 2 | 152700 | |
| Disease | entorhinal cortical volume | 3.75e-04 | 6 | 149 | 2 | EFO_0005092 | |
| Disease | Miller Dieker syndrome | 4.19e-04 | 29 | 149 | 3 | C0265219 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 4.19e-04 | 29 | 149 | 3 | C1333990 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a/b measurement | 5.23e-04 | 7 | 149 | 2 | EFO_0008211 | |
| Disease | peritonitis (biomarker_via_orthology) | 5.23e-04 | 7 | 149 | 2 | DOID:8283 (biomarker_via_orthology) | |
| Disease | lymphoid leukemia (is_implicated_in) | 5.23e-04 | 7 | 149 | 2 | DOID:1037 (is_implicated_in) | |
| Disease | ovarian neoplasm | 6.08e-04 | 134 | 149 | 5 | C0919267 | |
| Disease | alkaline phosphatase measurement | RAP1GAP TRIM2 ARHGAP10 C4orf36 ACTR1A SRRT FCGR2C FADS3 FCGR2B SLF2 XPO6 AKAP13 MTARC1 DCAF12 | 6.54e-04 | 1015 | 149 | 14 | EFO_0004533 |
| Disease | gut microbiome measurement, bone density | 6.66e-04 | 78 | 149 | 4 | EFO_0003923, EFO_0007874 | |
| Disease | Malignant neoplasm of ovary | 6.72e-04 | 137 | 149 | 5 | C1140680 | |
| Disease | health-related quality of life measurement | 8.91e-04 | 9 | 149 | 2 | EFO_0011014 | |
| Disease | plexin-B2 measurement | 8.91e-04 | 9 | 149 | 2 | EFO_0021867 | |
| Disease | triacylglycerol 54:1 measurement | 1.11e-03 | 10 | 149 | 2 | EFO_0010419 | |
| Disease | colorectal cancer (is_marker_for) | 1.24e-03 | 157 | 149 | 5 | DOID:9256 (is_marker_for) | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 1.34e-03 | 43 | 149 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | Systemic lupus erythematosus | 1.35e-03 | 11 | 149 | 2 | cv:C0024141 | |
| Disease | Pancreatic Neoplasm | 1.68e-03 | 100 | 149 | 4 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 1.81e-03 | 102 | 149 | 4 | C0346647 | |
| Disease | Leukemia, Myelocytic, Acute | 1.90e-03 | 173 | 149 | 5 | C0023467 | |
| Disease | multiple sclerosis (is_marker_for) | 1.96e-03 | 49 | 149 | 3 | DOID:2377 (is_marker_for) | |
| Disease | Fanconi anemia | 2.21e-03 | 14 | 149 | 2 | cv:C0015625 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 2.21e-03 | 14 | 149 | 2 | C0677776 | |
| Disease | autoimmune thrombocytopenic purpura (is_implicated_in) | 2.55e-03 | 15 | 149 | 2 | DOID:8924 (is_implicated_in) | |
| Disease | thrombosis (is_implicated_in) | 2.55e-03 | 15 | 149 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | Malaria, susceptibility to | 2.90e-03 | 16 | 149 | 2 | cv:C1970028 | |
| Disease | – | 2.90e-03 | 16 | 149 | 2 | 611162 | |
| Disease | body composition measurement | 3.04e-03 | 193 | 149 | 5 | EFO_0005106 | |
| Disease | Bone marrow hypocellularity | 3.67e-03 | 18 | 149 | 2 | C1855710 | |
| Disease | Ulcerative Colitis | 4.02e-03 | 63 | 149 | 3 | C0009324 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 4.09e-03 | 19 | 149 | 2 | C1333991 | |
| Disease | leukemia (implicated_via_orthology) | 4.09e-03 | 19 | 149 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 4.09e-03 | 19 | 149 | 2 | C2936783 | |
| Disease | esterified cholesterol measurement | 4.10e-03 | 128 | 149 | 4 | EFO_0008589 | |
| Disease | Liver carcinoma | 4.35e-03 | 507 | 149 | 8 | C2239176 | |
| Disease | Malaria | 4.53e-03 | 20 | 149 | 2 | C0024530 | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.77e-03 | 67 | 149 | 3 | C3463824 | |
| Disease | Arthrogryposis | 4.99e-03 | 21 | 149 | 2 | C0003886 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KFLSYRKISQCRMPS | 246 | Q7L211 | |
| EYLPTLRNICKTEKL | 1796 | Q96QE3 | |
| IKRKQCLQYLKTLRT | 21 | B9A014 | |
| KNLENYVCRPAIKTT | 101 | Q9NR48 | |
| NRYCIIRSSKQKCRL | 436 | Q8IYS0 | |
| TIFKRLRSVPTNKVC | 11 | Q9NP61 | |
| KLVQLYGVCTKQRPI | 456 | Q06187 | |
| LRKDYPAKILINLCT | 2771 | Q8IZF6 | |
| NITVRDTRCVYPKSL | 206 | Q8IWK6 | |
| SPARKAVSRYLRCLS | 166 | Q86XJ0 | |
| KEACRYALQVKPQRL | 966 | Q7Z2Z2 | |
| VALIYCRKKRISANS | 236 | P12318 | |
| VVALIYCRKKRISAL | 241 | P31994 | |
| LLNRVKKLPCQITSY | 196 | O95870 | |
| TIKERACYLSINPQK | 216 | P42025 | |
| TKYPVLFQRILQCTK | 2151 | Q12802 | |
| RNIYKQVTKKAPLCL | 106 | Q86SQ6 | |
| CDRVLRVYSIQKKRV | 191 | Q13112 | |
| KRKYRVCNVTRRPAS | 266 | Q9HCK5 | |
| ICIETLRLYTRKKPN | 281 | Q9UK58 | |
| LTTKNYIRTCTDIKP | 741 | O43143 | |
| PELSSKRNQCLLYKT | 31 | P0CE67 | |
| KATVLNYLPKCIRVS | 811 | P01023 | |
| KRKYRVCNVTRRPAS | 276 | Q9UKV8 | |
| QRLATLYKSPSQKEC | 321 | O43502 | |
| QKCGLSYKALVALRR | 41 | O75771 | |
| LKATVLNYLPKCIRV | 816 | P20742 | |
| LNYLPKCIRVSVQLK | 821 | P20742 | |
| QGPLDLTLKYCVRRK | 311 | O60890 | |
| KKRICRIITRDFPQY | 1136 | Q01484 | |
| RYIPKHQKCLTSAQR | 606 | Q8N7Z5 | |
| IHPLCLVSRYSQKLK | 896 | P0DP91 | |
| RKQYPRKILECVIKT | 126 | Q96IY1 | |
| RTKRPVAVYNLCLEL | 606 | A1A4S6 | |
| KCQLRLLKTLETNPY | 51 | Q9Y6H3 | |
| VQGPSCILKKYRLVL | 196 | Q6TGC4 | |
| KCNVKSFLVRIRDYP | 1016 | Q14667 | |
| TKPSKRQYQICLAID | 5376 | Q9NU22 | |
| LRSCPKVNSVYVLVR | 31 | Q8WVX9 | |
| LIAIVCYITQTRRKK | 526 | P20916 | |
| SRKEPLETLKSYRQC | 286 | Q5VT66 | |
| LPNYKSKILRLLCTV | 61 | Q09161 | |
| LALLQDRNTCPKYIK | 216 | Q99607 | |
| LKTSIPIKAICDYRQ | 886 | Q03001 | |
| VRVCLKEYQAKVTPT | 71 | Q9Y219 | |
| LLPTLRKQYCTLKEA | 576 | Q8NI77 | |
| IYELSSIPCRKRKVL | 86 | Q96MR6 | |
| KSNYEIRIRRPCEIK | 566 | Q5HYC2 | |
| VATKSIRPRYCKIQK | 401 | O75387 | |
| IRPRYCKIQKLTNAI | 406 | O75387 | |
| KPKQAACYLVRILFS | 501 | Q8NDZ0 | |
| SVRVFYKKCPLTVRN | 196 | P54764 | |
| VVALIYCRKKRISAN | 241 | P31995 | |
| YCRKKRISANSTDPV | 246 | P31995 | |
| RYLESCNLPSTTKRK | 636 | O15534 | |
| RLAPEIITATQYKKC | 1576 | Q9H792 | |
| TRKKRCPYTKHQTLE | 206 | P31269 | |
| QKSRIIKSDAYVCPL | 3031 | Q6ZR08 | |
| RIACVSAPSVYQKLR | 76 | Q8WVE0 | |
| RPTICQYCKRLLKGL | 281 | O94806 | |
| RCLTALPYICKRSNV | 941 | Q9UBG0 | |
| LPYICKRSNVTKETQ | 946 | Q9UBG0 | |
| RYRCLENSRSVVKTP | 736 | P07942 | |
| LRTPIRKKAMLTCTY | 836 | Q8NDA8 | |
| ITCTDPTTYKRRLQK | 2501 | P16112 | |
| KVQTKRLSCCLYKPR | 261 | Q9Y6X9 | |
| RKTKVARKTCNPTYN | 1556 | O00750 | |
| STAKLKRTLPCQAYV | 111 | Q86YD1 | |
| KNLVYGTTKKVCRRP | 446 | Q9H0J9 | |
| KYRVQPACKRLTLAT | 226 | P35227 | |
| KSQLLRYVLCTAPRA | 351 | P25205 | |
| RCKICRYLLVRTPKT | 106 | Q9Y2Y8 | |
| RSRKKTVPDIYICNL | 61 | Q969V1 | |
| RKRKLTICTYKVVPL | 2746 | Q13315 | |
| CPVKYSTQKILLVRN | 211 | Q4G0P3 | |
| RSNKPIHRAYCQIKV | 401 | Q6ISB3 | |
| KLLYVTPEKICASNR | 761 | P54132 | |
| KRQVQPLRSAYLSCL | 131 | Q96BQ5 | |
| KRCPVQAKYIQHLTR | 551 | Q9BQI3 | |
| SKLLSTKLPYCRENV | 286 | Q5T6F0 | |
| CSLKRLVLYRTKVEQ | 426 | Q9UKA2 | |
| KIKPTYRFRCLNVIL | 141 | P35575 | |
| LLERVYLSRKKVACP | 601 | Q7Z7M9 | |
| CAGLYPKVAKIRLNL | 836 | Q9H2U1 | |
| IAKLPCVAAKIYRNL | 206 | O75390 | |
| RSNKPIILRALCDYK | 456 | P15924 | |
| PDYLRKCLQSVKRLT | 96 | Q92819 | |
| SRPRLIECSYAKAKR | 536 | Q6P9A2 | |
| VRAPTLRTSIYQKCS | 601 | Q6ZUT9 | |
| KIPLVTNEECQKRYR | 536 | P03951 | |
| NKRSLRYIKRCLGAL | 191 | A0A0U1RQE8 | |
| AIKERACYLSINPQK | 216 | P61163 | |
| RKQPLDTLKSYRLCD | 286 | Q969Z3 | |
| CTLKIEYAKPTRLNV | 261 | P14866 | |
| VSRICKSPNERARLY | 4166 | Q14204 | |
| PRKNTVKTILRGSCY | 6 | Q96KX1 | |
| NYSRVAPLVKSLCAK | 396 | Q9Y5Q0 | |
| QPLASRRLTRKLYKC | 36 | Q9NX24 | |
| NAKEVYECRPRKVIS | 861 | P54277 | |
| AKAASIRDICKQRPY | 586 | Q5VW36 | |
| LNCLYPRKRLVKSES | 741 | Q96DY7 | |
| RRTKKTTEILKCYPV | 631 | P28827 | |
| ECLTPAIYAKLRNKV | 66 | P17540 | |
| KPTIILSAYQRKCIQ | 701 | Q99567 | |
| ICNPLRYRVITSKKV | 126 | Q8NGY7 | |
| LYQRAVRLRESPSCK | 746 | Q9Y2M0 | |
| TIPKLTAKSNCRYEI | 296 | P11717 | |
| PYSEKDTKQILRIRC | 361 | Q9Y230 | |
| IYLLPDRKCKLQTRV | 271 | Q5T7P8 | |
| CLTAPNYRLKSLQKK | 121 | Q16594 | |
| IPARYNSSRAKCIKC | 196 | P84550 | |
| ERYKPNDIVRILTCK | 261 | Q8WVZ7 | |
| CYAVIKGRPSKLRQS | 286 | Q9NWD8 | |
| YSPSAQVKRLLQACK | 506 | Q13671 | |
| YCKTAPNRAIRITKN | 521 | Q9Y3Z3 | |
| RSAYCSIVVTQPRKI | 176 | Q8NDG6 | |
| VCRTQKEDIKRVSPY | 241 | Q6ZSM3 | |
| SPYRKQVEKIRYCIT | 831 | Q9HCE1 | |
| LQTLRENVRKCLYPS | 1446 | Q8IZX4 | |
| LIPRKLCIKLIASTY | 151 | P0C617 | |
| TTKVKLECNPTARIY | 76 | P47736 | |
| VALPKRRCTASVNYK | 471 | Q5FBB7 | |
| YKFCKIRVRSVRIPQ | 916 | P30876 | |
| CTIRYRKIGPLVDKQ | 2061 | Q9NT68 | |
| ALYCDSRNLRKVPVI | 86 | P51888 | |
| SRRPCLSLASKYLAK | 131 | Q8IX21 | |
| LLCNIKPRRYLTVVF | 376 | Q99808 | |
| LRCYIRSKPALYQKV | 1756 | Q8IY92 | |
| KIPLKRCQFYRTRST | 481 | Q13591 | |
| NISRAEIISLCKRYP | 431 | Q9BXP5 | |
| FITNPRAVKKCTRYI | 51 | P45381 | |
| VLDLCSINKTTKPRY | 531 | Q96M20 | |
| KIEPIRRKGNYLLCS | 231 | Q6P4Q7 | |
| QPVCKLRKLIFTSVY | 656 | Q7RTR0 | |
| ECLTVPRYKRDLVQK | 361 | Q9HAU4 | |
| TLNRRCPKHIAKYLQ | 486 | Q9H4L4 | |
| PAVCYRIKSLRATLQ | 136 | P62380 | |
| AVYRVLKNCPSVALK | 51 | Q8N8B7 | |
| KSDTLPLATRYNVKC | 46 | Q15269 | |
| SAVKVLYQPCIKSRN | 321 | Q7Z6J8 | |
| LYQPCIKSRNEKLVS | 326 | Q7Z6J8 | |
| ASKTCRILQYRLRKA | 26 | O94964 | |
| RRLQTKPVITCFKSV | 6 | O43657 | |
| RVSLLRDCPNKKAIY | 1241 | P47989 | |
| ACRKYRRPTKQDSIQ | 741 | Q70Z35 | |
| DAYIVKNKPVELRCR | 56 | Q8IZJ1 | |
| RRYTIIPLNKISARC | 571 | O95347 | |
| LRCGLQYQKKTLRPR | 41 | Q9BVV7 | |
| QYQKKTLRPRCILGV | 46 | Q9BVV7 | |
| LTQEQKSCIREKPYR | 251 | Q09FC8 | |
| KLRALKCRQCSYTSP | 1261 | Q96JM2 | |
| YVKKTSLLANCQAPR | 626 | Q7Z403 | |
| KEQLSICVRYPQKSS | 656 | Q5SVZ6 | |
| ICVRYPQKSSKAILI | 661 | Q5SVZ6 | |
| ISCRPKTRISNKYRN | 246 | Q9NV72 | |
| TLPYFIRNKLCKVIV | 101 | Q96QU8 | |
| LICSICLERYKNPKV | 21 | Q9C040 | |
| KRYLRRSCLQQKAVL | 341 | Q53EQ6 | |
| CEQLRTLLPYVKGRK | 221 | Q9NX45 | |
| PRKLLVTYCSSCKLI | 516 | Q7Z402 | |
| KSLTLPQTCNREKIY | 266 | Q9NR11 | |
| PRSAKELRCQCIKTY | 26 | P10145 | |
| LDNLRKVVPCYSKTQ | 121 | Q13562 | |
| LDNLRKVVPCYSKTQ | 141 | Q15784 | |
| NLRKVVPCYSKTQKL | 116 | Q96NK8 |